KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Inventory (2020 - 2023)

Historic Inventory for Ginkgo Bioworks Holdings (DNA) over the last 4 years, with Q3 2023 value amounting to $70000.0.

  • Ginkgo Bioworks Holdings' Inventory fell 9880.55% to $70000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $70000.0, marking a year-over-year decrease of 9880.55%. This contributed to the annual value of $4.4 million for FY2022, which is 2980.37% up from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Inventory of $70000.0 as of Q3 2023, which was down 9880.55% from $391000.0 recorded in Q2 2023.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Inventory peaked at $8.7 million during Q1 2022, and registered a low of $70000.0 during Q3 2023.
  • Over the past 4 years, Ginkgo Bioworks Holdings' median Inventory value was $3.4 million (recorded in 2021), while the average stood at $4.0 million.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Inventory surged by 6868.16% in 2022, and later crashed by 9880.55% in 2023.
  • Ginkgo Bioworks Holdings' Inventory (Quarter) stood at $2.7 million in 2020, then rose by 22.88% to $3.4 million in 2021, then grew by 29.8% to $4.4 million in 2022, then tumbled by 98.4% to $70000.0 in 2023.
  • Its Inventory was $70000.0 in Q3 2023, compared to $391000.0 in Q2 2023 and $2.5 million in Q1 2023.